In an embryofetal development study in pregnant cynomolgus monkeys, subcutaneous doses of 0.015, 0.075, and 0.15 mg/kg twice weekly (1.0-, 5.2-, and 14.9-fold the MRHD) were administered throughout organogenesis, from Gestation Day 16 to 50
For any questions about missed doses or adjustments to the treatment plan, patients should consult their healthcare provider to ensure safe and effective weight management
Providers can best support lasting outcomes through structured weight-maintenance programs and continuous patient support long after semaglutide use concludes
These symptoms are often temporary and may subside as your body adjusts to the medication
FAQs Can semaglutide help with muscle gain
Our legal team will provide powerful representation, presenting evidence and expert testimonies to fight for the compensation you deserve